Understand the source comparison
Best Peptides for Brain Fog: Mechanism Comparison
The table below compares the most researched peptides for cognitive clarity based on primary mechanism, bioavailability, research depth, and clinical context. Semax BDNF/NGF upregulation, neuroplasticity enhancement Intranasal, subcutaneous Extensive. Multiple
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares the most researched peptides for cognitive clarity based on primary mechanism, bioavailability, research depth, and clinical context.
- Semax
- BDNF/NGF upregulation, neuroplasticity enhancement
- Intranasal, subcutaneous
- Extensive. Multiple Russian RCTs in stroke recovery
- Post-injury recovery, age-related cognitive decline
- Most extensively documented neuroplasticity peptide; ideal first-line research compound
- Cerebrolysin
- Neurotrophic factor delivery (BDNF, GDNF, NGF mimetics)
- Intramuscular, intravenous
- Extensive. 20+ meta-analyses in dementia and TBI
- Neurodegenerative disease models, vascular dementia
- Gold standard for neuroprotection research; complex peptide mixture limits mechanistic precision
- Dihexa
- HGF receptor activation, synaptogenesis
- Oral, subcutaneous
- Moderate. Preclinical and early phase I
- Severe cognitive impairment, Alzheimer's models
- Highest synaptogenic potency identified; narrow therapeutic window requires precise dosing
- SS-31 (Elamipretide)
- Mitochondrial cardiolipin binding, ATP optimization
- Subcutaneous, intravenous
- Moderate. Phase II trials in mitochondrial disease
- Mitochondrial dysfunction, Parkinson's models
- Best-in-class for bioenergetic rescue; requires acute timing for maximal benefit
- P21
- Calpain inhibition, anti-apoptotic neuroprotection
- Moderate. Extensive TBI preclinical data
- Acute brain injury, excitotoxicity models
- Potent neuroprotectant with narrow therapeutic window; most effective in acute injury protocols
- Selank
- GABA-A modulation, MAO inhibition, HPA axis regulation
- Moderate. Russian clinical trials in anxiety and ADHD
- Anxiety-driven cognitive impairment
- Best anxiolytic profile without sedation; particularly effective when stress is a primary contributor
- VIP
- Microglial cytokine suppression, anti-inflammatory
- Moderate. Preclinical neuroinflammation models
- Post-viral syndrome, autoimmune-driven brain fog
- Direct neuroinflammation targeting; most relevant in immune-mediated cognitive impairment
- KPV
- NF-κB inhibition, melanocortin receptor activation
- Limited. Emerging data in GI inflammation
- Peripheral inflammation with CNS crossover
- Promising but under-researched for CNS applications; better data in GI inflammation contexts
- The comparison reveals a critical insight: no single peptide addresses all mechanisms driving brain fog. Semax and Cerebrolysin dominate the neuroplasticity category with the deepest clinical data. SS-31 and P21 lead mitochondrial and neuroprotective applications. Selank and VIP target the immune-stress axis most effectively.